Table 2 Multivariate analysis of different prognostic factors in human lung ADC patients (n = 150).
From: High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma
Expression level | Variable | HR | 95% CI | P value |
|---|---|---|---|---|
The protein level expression of SOX30 | Age | 1.056 | 1.024–1.090 | 0.001 |
Gender | 0.796 | 0.410–1.546 | 0.500 | |
Clinical stage | 1.962 | 1.393–2.765 | 0.000 | |
Histological grade | 0.968 | 0.599–1.565 | 0.895 | |
Tumor size | 0.860 | 0.698–1.060 | 0.157 | |
Lymph node status | 1.036 | 0.955–1.123 | 0.397 | |
SOX30 expression | 0.405 | 0.112–0.561 | 0.000 |
